Psoriasis improvement and satisfaction in patients using a clobetasol spray and oral apremilast combination regimen: A pilot study - 08/09/20
Funding sources: This study was funded by Celgene Corporation. |
|
Conflicts of interest: Dr Prussick is a member of the National Psoriasis Foundation, serves as a speaker for Celgene Corporation, and received research grants from Celgene Corporation. Mr Wei and Dr Friedman have no conflicts of interest to declare. |
|
IRB approval status: Reviewed and approved by Western Institutional Review Board (clinicaltrials.gov: NCT03453190). |
Vol 83 - N° 4
P. 1198-1200 - octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?